Results 21 to 30 of about 4,083,225 (263)

High-Intensity Statin on 3-Year Clinical Outcomes in Elderly Acute Myocardial Infarction Patients Underwent Percutaneous Coronary Intervention With Drug-Eluting Stents

open access: yesScientific Reports
There is limited data on high-intensity statin for secondary prevention in elderly acute myocardial infarction (AMI) patients above 75 years. This study aimed to assess the impact of high-intensity statin on 3-year outcomes in elderly AMI patients (> 75 ...
Seung-Woon Rha   +2 more
exaly   +2 more sources

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation

open access: yesLife, 2021
Constituting hypolipidemic and pleiotropic effects, statins stabilize coronary artery plaque and may prevent STEMI events. This study investigated the association between contemporary statin pretreatment intensity, low-density lipoprotein cholesterol ...
Ziv Dadon   +7 more
doaj   +2 more sources

High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background 2018 American Heart Association/American College of Cardiology cholesterol guideline recommends statin in patients with chronic and/or stable liver disease for secondary prevention of atherosclerotic cardiovascular disease yet remains ...
Sungho Bea   +6 more
doaj   +2 more sources

Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study

open access: yesScientific Reports
The long-term outcome of first-line moderate-intensity statin with ezetimibe combination therapy for secondary prevention after percutaneous coronary intervention in patients with acute coronary syndrome (ACS) compared to high-intensity statin ...
Ji-Yong Jang   +5 more
doaj   +2 more sources

Association between the intensity of statin therapy and physical activity 1 year after acute coronary syndrome: a multicentre prospective cohort study in Switzerland

open access: yesBMJ Open
Objectives To assess the association between the intensity of statin therapy and the level of physical activity in patients 1 year after an acute coronary syndrome (ACS).Design Prospective cohort study from the Special Program University Medicine-Acute ...
David Nanchen   +12 more
doaj   +3 more sources

The “Chinese Dose” of statin

open access: yesCardiology Plus, 2016
The benefits of atherosclerotic cardiovascular disease prevention/treatment and lipid-lowering therapy come from the reduction of cholesterol itself. However, based on safety considerations, all guidelines note that high-intensity statin therapy is not ...
Ping Ye
doaj   +2 more sources

Safety and Efficacy of Moderate-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Monotherapy in Patients With Atherosclerotic Cardiovascular Disease: A Meta-Analysis

open access: yesJournal of Clinical Lipidology
BACKGROUND Atherosclerotic cardiovascular disease (ASCVD), affects approximately 18.6 million individuals worldwide and poses a significant healthcare related challenge. Despite the established efficacy of both high-intensity statin monotherapy (HIS) and
Francisco Cezar Aquino de Moraes   +2 more
exaly   +2 more sources

A systematic review and meta-analysis of the effect of high-intensity statin on coronary microvascular dysfunction

open access: yesBMC Cardiovascular Disorders, 2023
Objective The purpose of this meta-analysis is to evaluate the role of high-intensity statin pretreatment on coronary microvascular dysfunction in patients with coronary heart disease undergoing percutaneous coronary intervention (PCI).
Bihan Huang   +3 more
doaj   +2 more sources

Metabolic and Safety Outcomes of Statin-Ezetimibe Versus High-Intensity Statin in Older Patients. [PDF]

open access: yesJ Am Heart Assoc
Background High‐intensity statins are recommended for secondary prevention in atherosclerotic cardiovascular disease (ASCVD), but older adults frequently experience tolerability issues and adverse metabolic effects.
Cha JJ   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy